12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
Product identity: KS-2019-339-TSO
Client/Metrc ID: Terpsolate
Customer:
12/16/19 13:08Sample Date:19-015330-0001Laboratory ID:
Klersun
SummaryPotency:
96.0%CBD-Total
< 0.178%THC-Total
(Reported in percent of total sample)
CBD
CBDV
Analyte Result (%)96.0CBD
0.483CBDV†
Terpenes:
Analyte Percentby weight
Percentof Total
Analyte Percentby weight
Percentof Total
0.568farnesene† 42.71% 0.293a-Bisabolol† 22.03%
0.240(-)-Guaiol† 18.05% 0.0809ß-Caryophyllene† 6.08%
0.0543(-)-caryophyllene oxide† 4.08% 0.0497Humulene† 3.74%
0.0453(±)-trans-Nerolidol† 3.41% 1.33Total Terpenes† 100.00%
Page 1 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
Customer: Klersun3448 NE Broadway StPortland Oregon 97232United States
Product identity: KS-2019-339-TSO
12/16/19 13:08Sample Date:
19-015330-0001Laboratory ID:
Client/Metrc ID: Terpsolate
Received By MailRelinquished by:
15.7 °CTemp:
Sample ResultsPotency Batch 1911617Method J AOAC 2015 V98-6 Units % Analyze 12/21/19 04:55 AMAnalyte As
ReceivedDryweight
LOQ Notes
< LOQCBC† 0.0951
< LOQCBC-A† 0.0951
< LOQCBC-Total† 0.178
96.0CBD 0.951
< LOQCBD-A 0.0951
96.0CBD-Total 1.03
0.483CBDV† 0.0951
< LOQCBDV-A† 0.0951
0.483CBDV-Total† 0.177
< LOQCBG† 0.0951
< LOQCBG-A† 0.0951
< LOQCBG-Total† 0.177
< LOQCBL† 0.0951
< LOQCBN 0.0951
< LOQ∆8-THC† 0.0951
< LOQ∆9-THC 0.0951
< LOQTHC-A 0.0951
< LOQTHC-Total 0.178
< LOQTHCV† 0.0951
< LOQTHCV-A† 0.0951
< LOQTHCV-Total† 0.177
CBD
CBDV
Page 2 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
Terpenes Batch 1911443Method J AOAC 2015 V98-6 Units % Analyze 12/17/19 06:14 PM
LOQAnalyte Result Notes% of Total LOQAnalyte Result Notes% of Total
0.568farnesene† 42.71%0.020 0.293a-Bisabolol† 22.03%0.020
0.240(-)-Guaiol† 18.05%0.020 0.0809ß-Caryophyllene† 6.08%0.020
0.0543(-)-caryophyllene oxide† 4.08%0.020 0.0497Humulene† 3.74%0.020
0.0453(±)-trans-Nerolidol† 3.41%0.020 < LOQ(-)-a-Terpineol† 0.00%0.020
< LOQ(-)-Isopulegol† 0.00%0.020 < LOQ(-)-ß-Pinene† 0.00%0.020
< LOQ(+)-Borneol† 0.00%0.020 < LOQ(+)-Cedrol† 0.00%0.020
< LOQ(+)-fenchol† 0.00%0.020 < LOQ(+)-Pulegone† 0.00%0.020
< LOQ(±)-Camphor† 0.00%0.020 < LOQ(±)-cis-Nerolidol† 0.00%0.020
< LOQ(±)-fenchone† 0.00%0.020 < LOQ(R)-(+)-Limonene† 0.00%0.020
< LOQa-cedrene† 0.00%0.020 < LOQa-phellandrene† 0.00%0.020
< LOQa-pinene† 0.00%0.020 < LOQa-Terpinene† 0.00%0.020
< LOQCamphene† 0.00%0.020 < LOQcis-ß-Ocimene† 0.00%0.006
< LOQd-3-Carene† 0.00%0.020 < LOQEucalyptol† 0.00%0.020
< LOQgamma-Terpinene† 0.00%0.020 < LOQGeraniol† 0.00%0.020
< LOQGeranyl acetate† 0.00%0.020 < LOQIsoborneol† 0.00%0.020
< LOQLinalool† 0.00%0.020 < LOQMenthol† 0.00%0.020
< LOQnerol† 0.00%0.020 < LOQp-Cymene† 0.00%0.020
< LOQSabinene† 0.00%0.020 < LOQSabinene hydrate† 0.00%0.020
< LOQß-Myrcene† 0.00%0.020 < LOQTerpinolene† 0.00%0.020
< LOQtrans-ß-Ocimene† 0.00%0.013 < LOQvalencene† 0.00%0.020
Total Terpenes 1.33
farn
esen
e
a-B
isab
olol
(-)-
Gua
iol
ß-C
aryo
phyl
lene
(-)-
cary
ophy
llene
ox
ide
Hum
ulen
e
(±)-
tran
s-N
erol
idol
%
Page 3 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
42.71 %farnesene
22.03 %a-Bisabolol
18.05 %(-)-Guaiol
6.08 %ß-Caryophyllene
4.08 %(-)-caryophyllene oxide
3.74 %Humulene
3.41 %(±)-trans-Nerolidol
Page 4 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
These test results are representative of the individual sample selected and submitted by the client.
AbbreviationsLimits: Action Levels per OAR-333-007-0400, OAR-333-007-0210, OAR-333-007-0220Limit(s) of Quantitation (LOQ): The minimum levels, concentrations, or quantities of a target variable (e.g., target analyte) that can be
reported with a specified degree of confidence.
† = Analyte not NELAP accredited.
Units of Measure
% = Percentage of sample
% wt = µg/g divided by 10,000
Derrick TannerGeneral Manager
Approved Signatory
Page 5 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
Page 6 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
Page 7 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
EPA 5035 Batch ID:Method Blank Laboratory Control SampleAnalyte Notes Result LCS Spike Units LCS % Rec Notesa-pinene < 200 541 500 µg/g 108.3 70 - 130Camphene < 200 428 500 µg/g 85.6 70 - 130Sabinene < 200 541 500 µg/g 108.1 70 - 130b-Pinene < 200 539 500 µg/g 107.8 70 - 130b-Myrcene < 200 440 500 µg/g 87.9 70 - 130a-phelllandrene < 200 432 500 µg/g 86.4 70 - 130d-3-Carene < 200 417 500 µg/g 83.5 70 - 130a-Terpinene < 200 541 500 µg/g 108.2 70 - 130p-Cymene < 200 431 500 µg/g 86.3 70 - 130D-Limonene < 200 536 500 µg/g 107.1 70 - 130Eucalyptol < 200 437 500 µg/g 87.5 70 - 130b-cis-Ocimene < 66.7 136 167 µg/g 81.5 70 - 130b-trans-Ocimene < 133 320 333 µg/g 96.1 70 - 130g-Terpinene < 200 580 500 µg/g 116.1 70 - 130Sabinene_Hydrate < 200 559 500 µg/g 111.7 70 - 130Terpinolene < 200 538 500 µg/g 107.6 70 - 130D-Fenchone < 200 534 500 µg/g 106.8 70 - 130Linalool < 200 420 500 µg/g 84.0 70 - 130Fenchol < 200 539 500 µg/g 107.9 70 - 130Camphor < 200 447 500 µg/g 89.5 70 - 130Isopulego < 200 435 500 µg/g 87.0 70 - 130Isoborneol < 200 448 500 µg/g 89.5 70 - 130Borneol < 200 553 500 µg/g 110.5 70 - 130DL-Menthol < 200 437 500 µg/g 87.5 70 - 130Terpineol < 200 523 500 µg/g 104.6 70 - 130Nerol < 200 433 500 µg/g 86.5 70 - 130Pulegone < 200 553 500 µg/g 110.6 70 - 130Gereniol < 200 532 500 µg/g 106.3 70 - 130Geranyl_Acetate < 200 439 500 µg/g 87.8 70 - 130a-Cedrene < 200 528 500 µg/g 105.5 70 - 130b-Caryophyllene < 200 439 500 µg/g 87.7 70 - 130a-Humulene < 200 547 500 µg/g 109.4 70 - 130Valenene < 200 465 500 µg/g 93.0 70 - 130cis-Nerolidol < 200 449 500 µg/g 89.9 70 - 130a-Farnesene < 200 612 500 µg/g 122.4 70 - 130trans-Nerolidol < 200 554 500 µg/g 110.9 70 - 130Caryophyllene_Oxide < 200 439 500 µg/g 87.8 70 - 130Guaiol < 200 564 500 µg/g 112.8 70 - 130Cedrol < 200 448 500 µg/g 89.6 70 - 130a-Bisabolol < 200 447 500 µg/g 89.3 70 - 130
Laboratory Terpene Quality Control Results1911443
Blank LimitsResultNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDNDND
NDND
NDNDNDNDND
ND
NDNDNDNDNDND
NDND
NDNDND
NDNDND
Page 8 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
Sample/Sample Duplicate Sample ID:Analyte Result Org. Result LOQ Units RPD, % Notesa-pinene 1962 1631 200 µg/g 9.21 < 20 80 - 120Camphene 228.5 ND 200 µg/g 0 < 20 80 - 120Sabinene ND ND 200 µg/g 0 < 20 80 - 120b-Pinene 1417 1184 200 µg/g 8.96 < 20 80 - 120b-Myrcene 7369 6158 200 µg/g 8.95 < 20 80 - 120a-phelllandrene ND ND 200 µg/g 0 < 20 80 - 120d-3-Carene ND ND 200 µg/g 0 < 20 80 - 120a-Terpinene ND ND 200 µg/g 0 < 20 80 - 120p-Cymene ND ND 200 µg/g 0 < 20 80 - 120D-Limonene 16980 14240 200 µg/g 8.78 < 20 80 - 120Eucalyptol ND ND 200 µg/g 0 < 20 80 - 120b-cis-Ocimene 119.5 96.4 66.7 µg/g 10.7 < 20 80 - 120b-trans-Ocimene 1578 1304 133 µg/g 9.51 < 20 80 - 120g-Terpinene ND ND 200 µg/g 0 < 20 80 - 120Sabinene_Hydrate ND ND 200 µg/g 0 < 20 80 - 120Terpinolene 2076 1737 200 µg/g 8.89 < 20 80 - 120D-Fenchone ND ND 200 µg/g 0 < 20 80 - 120Linalool 1116 913.2 200 µg/g 10 < 20 80 - 120Fenchol 1438 1191 200 µg/g 9.40 < 20 80 - 120Camphor ND ND 200 µg/g 0 < 20 80 - 120Isopulego ND ND 200 µg/g 0 < 20 80 - 120Isoborneol ND ND 200 µg/g 0 < 20 80 - 120Borneol 353.6 300.5 200 µg/g 8.12 < 20 80 - 120DL-Menthol ND ND 200 µg/g 0 < 20 80 - 120Terpineol 1108 917.8 200 µg/g 9.39 < 20 80 - 120Nerol ND ND 200 µg/g 0 < 20 80 - 120Pulegone ND ND 200 µg/g 0 < 20 80 - 120Gereniol ND ND 200 µg/g 0 < 20 80 - 120Geranyl_Acetate ND ND 200 µg/g 0 < 20 80 - 120a-Cedrene ND ND 200 µg/g 0 < 20 80 - 120b-Caryophyllene 29850 24760 200 µg/g 9.32 < 20 80 - 120a-Humulene 11660 9811 200 µg/g 8.61 < 20 80 - 120Valenene ND ND 200 µg/g 0 < 20 80 - 120cis-Nerolidol ND ND 200 µg/g 0 < 20 80 - 120a-Farnesene 25250 20070 200 µg/g 11.4 < 20 80 - 120trans-Nerolidol 323.8 321.9 200 µg/g 0.29 < 20 80 - 120Caryophyllene_Oxide 618.1 501.7 200 µg/g 10.4 < 20 80 - 120Guaiol ND ND 200 µg/g 0 < 20 80 - 120Cedrol ND ND 200 µg/g 0 < 20 80 - 120a-Bisabolol 7336 6130 200 µg/g 8.96 < 20 80 - 120
Sample Duplicate % Limits19-015204-0001
Page 9 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
Revision #: 0.00 Control : CFL-D06Revision Date: 05/31/2019 Effective Date: 05/31/2019
J AOAC 2015 V98-6 Batch ID:Laboratory Control SampleAnalyte Result Spike Units % Rec Evaluation Notes
CBDV-A 0.204 0.2 102 85.0 - 115 Acceptable
CBDV 0.207 0.2 103 85.0 - 115 Acceptable
CBD-A 0.204 0.2 102 85.0 - 115 Acceptable
CBG-A 0.207 0.2 103 85.0 - 115 Acceptable
CBG 0.205 0.2 103 85.0 - 115 Acceptable
CBD 0.198 0.2 99.1 85.0 - 115 Acceptable
THCV 0.200 0.2 100 85.0 - 115 Acceptable
THCVA 0.198 0.2 99.1 85.0 - 115 Acceptable
CBN 0.195 0.2 97.3 85.0 - 115 Acceptable
THC 0.196 0.2 98.2 85.0 - 115 Acceptable
D8THC 0.206 0.2 103 85.0 - 115 Acceptable
CBL 0.196 0.2 98.2 85.0 - 115 Acceptable
CBC 0.208 0.2 104 85.0 - 115 Acceptable
THCA 0.187 0.2 93.7 85.0 - 115 Acceptable
CBCA 0.200 0.2 99.9 85.0 - 115 Acceptable
Method BlankAnalyte Result LOQ Units Evaluation Notes
CBDV-A <LOQ 0.1 < Acceptable
CBDV <LOQ 0.1 < Acceptable
CBD-A <LOQ 0.1 < Acceptable
CBG-A <LOQ 0.1 < Acceptable
CBG <LOQ 0.1 < Acceptable
CBD <LOQ 0.1 < Acceptable
THCV <LOQ 0.1 < Acceptable
THCVA <LOQ 0.1 < Acceptable
CBN <LOQ 0.1 < Acceptable
THC <LOQ 0.1 < Acceptable
D8THC <LOQ 0.1 < Acceptable
CBL <LOQ 0.1 < Acceptable
CBC <LOQ 0.1 < Acceptable
THCA <LOQ 0.1 < Acceptable
CBCA <LOQ 0.1 < Acceptable
AbbreviationsND - None Detected at or above MRL
RPD -Relative Percent Difference
LOQ - Limit of Quantitation
Units of Measure:
% - Percent
% 0.1
% 0.1
0.1
0.1
0.1
%
%
0.1
%
%
%
%
%
0.1%
%
%
%
% 0.1
0.1
0.1
% 0.1
% 0.1
0.1
Laboratory Quality Control Results1911617
Limits
%
%
%
%
%
%
%
%
%
0.1
%
Limits
%
%
%
%
0.1
Page 10 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
Revision #: 0.00 Control : CFL-D06Revision Date: 05/31/2019 Effective Date: 05/31/2019
Laboratory Quality Control ResultsJ AOAC 2015 V98-6 Batch ID:Sample Duplicate Sample ID:
Analyte Result Org. Result LOQ Units RPD Evaluation Notes
CBDV-A <LOQ <LOQ 0.1 NA < Acceptable
CBDV <LOQ <LOQ 0.1 NA < Acceptable
CBD-A 0.150 0.171 0.1 13.7 < Acceptable
CBG-A 1.39 1.60 0.1 14.4 < Acceptable
CBG 0.177 0.203 0.1 13.5 < Acceptable
CBD <LOQ <LOQ 0.1 NA < Acceptable
THCV <LOQ <LOQ 0.1 NA < Acceptable
THCVA 0.238 0.236 0.1 0.770 < Acceptable
CBN <LOQ <LOQ 0.1 NA < Acceptable
THC 0.494 0.596 0.1 18.8 < Acceptable
D8THC <LOQ <LOQ 0.1 NA < Acceptable
CBL <LOQ <LOQ 0.1 NA < Acceptable
CBC <LOQ <LOQ 0.1 NA < Acceptable
THCA 85.7 79.9 0.1 7.04 < Acceptable
CBCA 1.13 1.26 0.1 11.5 < Acceptable
AbbreviationsND - None Detected at or above MRL
RPD -Relative Percent Difference
LOQ - Limit of Quantitation
NA - Calculation Not Applicable given non-numerical results
Units of Measure:
% - Percent
% 20
% 20
% 20
%
19-015204-0006
% 20
% 20
20
1911617
% 20
% 20
Limits
% 20
% 20
% 20
% 20
20
% 20
%
% 20
Page 11 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430
12423 NE Whitaker WayPortland, OR 97230
503-254-1794
Report Number:
Report Date:
ORELAP#:
12/24/2019
OR100028
10:25Received: 12/17/19
Purchase Order:
19-015330/D02.R00
Code Explanation
Q Matrix interferences affecting spike or surrogate recoveries.
Q1 Quality control result biased high. Only non-detect samples reported.
Q2 Quality control outside QC limits. Data considered estimate.
Q3 Sample concentration greater than four times the amount spiked.
Q4 Non-homogenous sample matrix, affecting RPD result and/or % recoveries.
Q5 Spike results above calibration curve.
Q6 Quality control outside QC limits. Data acceptable based on remaining QC.
R Relative percent difference (RPD) outside control limit.
R1 RPD non-calculable, as sample or duplicate results are less than five times the LOQ.
R2 Sample replicates RPD non-calculable, as only one replicate is within the analytical range.
LOQ1 Quantitation level raised due to low sample volume and/or dilution.
LOQ2 Quantitaion level raised due to matrix interference.
B Analyte detected in method blank, but not in associated samples.
B1 The sample concentration is greater than 5 times the blank concentration.
B2 The sample concentration is less than 5 times the blank concentration.
Explanation of QC Flag Comments:
Page 12 of 12Test results relate only to the parameters tested and to the samples as received by the laboratory. Test results meet all requirements of NELAP and the Pixis quality assurance plan unlessotherwise noted. This report shall not be reproduced, except in full, without the written consent of this laboratory. Samples will be retained for a maximum of 30 days from the receipt date unlessprior arrangements have been made.
Testing in accordance with: OAR 333-007-0430